SCL trades 34.9% below Wall Street's consensus target of $85.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes SCL achieves its forward estimates and maintains a stable P/E multiple of 23.4x. This scenario reflects the blended consensus of 3 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of October 3, 2026, Stepan Co (SCL) has a Wall Street consensus price target of $85.00, based on estimates from 3 covering analysts. With the stock currently trading at $63.00, this represents a potential upside of +34.9%. The company has a market capitalization of $1.43B.
Analyst price targets range from a low of $85.00 to a high of $85.00, representing a 0% spread in expectations. The median target of $85.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 3 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, SCL trades at a trailing P/E of 30.7x and forward P/E of 23.4x. Analysts expect EPS to grow +2423.0% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $41.58, with bear and bull scenarios of $26.19 and $54.78 respectively. Model confidence stands at 41/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 IOSPInnospec Inc. | $2.4B | $97.41 | $110.00 | +12.9% | Hold | 19.7x | 9 |
 BCPCBalchem Corp | $5.4B | $166.56 | $215.00 | +29.1% | Buy | 30.8x | 10 |
 HWKNHawkins, Inc. | $2.7B | $131.41 | $142.00 | +8.1% | Buy | 33.4x | 2 |
 ASIXAdvanSix Inc. | $437M | $16.22 | $30.80 | +89.9% | Buy | 87.7x | 6 |
 KWRQuaker Houghton | $2.8B | $160.73 | $182.50 | +13.5% | Buy | 20.4x | 16 |
 RPMRPM International Inc. | $12.7B | $99.19 | $132.86 | +33.9% | Buy | 18.0x | 22 |
 CBTCabot Corp. | $4.0B | $76.95 | $94.00 | +22.2% | Buy | 12.1x | 15 |
 HUNHuntsman Corporation | $1.5B | $8.53 | $11.57 | +35.6% | Hold | — | 33 |
 TROXTronox Holdings plc | $627M | $3.93 | $7.57 | +92.6% | Buy | — | 17 |
 KRNTKornit Digital Ltd. | $810M | $17.49 | $19.00 | +8.6% | Buy | 82.5x | 13 |
Quick answers to the most common questions about buying SCL stock.
The consensus Wall Street price target for SCL is $85, representing 34.9% upside from the current price of $63. With 3 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
SCL has a consensus rating of "Buy" based on 3 Wall Street analysts. The rating breakdown is predominantly bullish, with 3 Buy/Strong Buy ratings. The consensus 12-month price target of $85 implies 34.9% upside from current levels.
SCL trades at a forward P/E of 23.4201x, representing a moderate valuation. With analysts targeting $85 (34.9% implied move), the stock appears reasonably valued with upside.
The most bullish Wall Street analyst has a price target of $85 for SCL, while the most conservative target is $85. The consensus of $85 represents the median expectation. Our quantitative valuation model projects a bull case target of $55 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
SCL is lightly followed, with 3 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month SCL stock forecast based on 3 Wall Street analysts shows a consensus price target of $85, with estimates ranging from $85 (bear case) to $85 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $42, with bear/bull scenarios of $26/$55.
Our quantitative valuation model calculates SCL's fair value at $42 (base case), with a bear case of $26 and bull case of $55. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 41/100.
SCL trades at a forward P/E ratio of 23.4x based on next-twelve-months earnings estimates compared to a trailing P/E of 30.7x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on SCL, with a "Buy" consensus rating and $85 price target (34.9% upside). 3 of 3 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
SCL analyst price targets range from $85 to $85, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $85 consensus represents the middle ground. Our model's $26-$55 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.